# EDGAR Filing Document

**Accession Number:** 0001994702
**File Stem:** 0000919574-25-007080
**Filing Date:** 2025-11
**Character Count:** 18151
**Document Hash:** db087f9b0c732dd0e8964b123b7f2546
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000919574-25-007080.hdr.sgml**: 20251117

**ACCESSION NUMBER**: 0000919574-25-007080

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20251117

**DATE AS OF CHANGE**: 20251117

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kyverna Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001994702
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 831365441
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94441
- **FILM NUMBER:** 251490904

**BUSINESS ADDRESS:**
- **STREET 1:** 5980 HORTON STREET
- **STREET 2:** SUITE 550
- **CITY:** EMERYVILLE
- **STATE:** CA
- **ZIP:** 94608
- **BUSINESS PHONE:** 5106268331

**MAIL ADDRESS:**
- **STREET 1:** 5980 HORTON STREET
- **STREET 2:** SUITE 550
- **CITY:** EMERYVILLE
- **STATE:** CA
- **ZIP:** 94608
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GordonMD Global Investments LP
- **CENTRAL INDEX KEY:** 0002039349

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 1436 5TH STREET
- **STREET 2:** SUITE 3-210
- **CITY:** MANHATTAN BEACH
- **STATE:** CA
- **ZIP:** 90266
- **BUSINESS PHONE:** 424-200-6630

**MAIL ADDRESS:**
- **STREET 1:** 1436 5TH STREET
- **STREET 2:** SUITE 3-210
- **CITY:** MANHATTAN BEACH
- **STATE:** CA
- **ZIP:** 90266

## Ex-99

<u>Exhibit A</u>

<u>JOINT FILING AGREEMENT</u>

The undersigned agree that this Schedule 13G dated November 17, 2025 relating to the Common Stock, par value $0.00001 per share, of Kyverna Therapeutics, Inc. shall be filed on behalf of the undersigned.

---

| |
|:---|
| &nbsp;&nbsp; GORDONMD GLOBAL INVESTMENTS LP<br>By: /s/ GordonMD Global Investments GP LLC |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Craig D. Gordon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member of the General Partner |

---

---

| |
|:---|
| &nbsp;&nbsp; GORDONMD LONG BIASED MASTER FUND LP<br>By: /s/ GordonMD Long Biased GP LLC |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Craig D. Gordon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member of the General Partner |

---

---

| |
|:---|
| &nbsp;&nbsp; GORDONMD LONG BIASED GP LLC<br>By: /s/ Craig D. Gordon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Craig D. Gordon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member |

---

&nbsp;&nbsp; CRAIG D. GORDON<br>By: /s/ Craig D. Gordon<br>

---

| |
|:---|
| &nbsp;&nbsp; GORDONMD GLOBAL INVESTMENTS GP LLC<br>By: /s/ Craig D. Gordon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Craig D. Gordon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member |

---

## Ex-99

<u>Exhibit B</u>

<u>CONTROL PERSON IDENTIFICATION</u>

GordonMD Global Investments LP is the relevant entity for which Craig D. Gordon and GordonMD Global Investments GP LLC may be considered control persons.

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Kyverna Therapeutics, Inc.

**Title of Class of Securities:** Common Stock, par value $0.00001 per share

**CUSIP Number:** 501976104

**Date of Event Which Requires Filing of this Statement:** 11/13/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>GordonMD Global Investments LP | Names of Reporting Persons<br>GordonMD Global Investments LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>3058485.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>3058485.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3058485.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3058485.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>7.0% | Percent of Class Represented by Amount in Row (9)<br>7.0% |
| 12. | Type of Reporting Person (See Instructions)<br>IA, PN | Type of Reporting Person (See Instructions)<br>IA, PN |

---

| 1. | Names of Reporting Persons<br>GordonMD Long Biased Master Fund LP | Names of Reporting Persons<br>GordonMD Long Biased Master Fund LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>E9 | Citizenship or Place of Organization<br>E9 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>2735783.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>2735783.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2735783.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2735783.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>6.2% | Percent of Class Represented by Amount in Row (9)<br>6.2% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

---

| 1. | Names of Reporting Persons<br>GordonMD Long Biased GP LLC | Names of Reporting Persons<br>GordonMD Long Biased GP LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>2735783.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>2735783.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2735783.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2735783.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>6.2% | Percent of Class Represented by Amount in Row (9)<br>6.2% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

---

| 1. | Names of Reporting Persons<br>Craig D. Gordon | Names of Reporting Persons<br>Craig D. Gordon |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>3058485.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>3058485.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3058485.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3058485.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>7.0% | Percent of Class Represented by Amount in Row (9)<br>7.0% |
| 12. | Type of Reporting Person (See Instructions)<br>HC, IN | Type of Reporting Person (See Instructions)<br>HC, IN |

---

| 1. | Names of Reporting Persons<br>GordonMD Global Investments GP LLC | Names of Reporting Persons<br>GordonMD Global Investments GP LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>3058485.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>3058485.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3058485.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>3058485.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>7.0% | Percent of Class Represented by Amount in Row (9)<br>7.0% |
| 12. | Type of Reporting Person (See Instructions)<br>HC, OO | Type of Reporting Person (See Instructions)<br>HC, OO |

---

**Item 1(a). Name of Issuer:**
Kyverna Therapeutics, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
5980 HORTON STREET, SUITE 550, EMERYVILLE, CA, 94608

**Item 2(a). Name of Person Filing:**
GordonMD Global Investments LP
GordonMD Long Biased Master Fund LP
GordonMD Long Biased GP LLC
Craig D. Gordon
GordonMD Global Investments GP LLC

**Item 2(b). Address of Principal Business Office:**
GordonMD Global Investments LP
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212

GordonMD Long Biased Master Fund LP
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212

GordonMD Long Biased GP LLC
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212

Craig D. Gordon
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212

GordonMD Global Investments GP LLC
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212

**Item 2(c). Citizenship:**
GordonMD Global Investments LP - Delaware
GordonMD Long Biased Master Fund LP - Cayman Islands
GordonMD Long Biased GP LLC - Delaware
Craig D. Gordon - United States
GordonMD Global Investments GP LLC - Delaware

**Item 2(d). Title of Class of Securities:**
Common Stock, par value $0.00001 per share

**Item 2(e). CUSIP Number:**
501976104

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

GordonMD Global Investments LP - 3,058,485
GordonMD Long Biased Master Fund LP - 2,735,783
GordonMD Long Biased GP LLC - 2,735,783
Craig D. Gordon - 3,058,485
GordonMD Global Investments GP LLC - 3,058,485

**(b) Percent of class:**

GordonMD Global Investments LP - 7.0%
GordonMD Long Biased Master Fund LP - 6.2%
GordonMD Long Biased GP LLC - 6.2%
Craig D. Gordon - 7.0%
GordonMD Global Investments GP LLC - 7.0%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

GordonMD Global Investments LP - 0
GordonMD Long Biased Master Fund LP - 0
GordonMD Long Biased GP LLC - 0
Craig D. Gordon - 0
GordonMD Global Investments GP LLC - 0

**(ii) Shared power to vote or to direct the vote:**

GordonMD Global Investments LP - 3,058,485
GordonMD Long Biased Master Fund LP - 2,735,783
GordonMD Long Biased GP LLC - 2,735,783
Craig D. Gordon - 3,058,485
GordonMD Global Investments GP LLC - 3,058,485

**(iii) Sole power to dispose or to direct the disposition of:**

GordonMD Global Investments LP - 0
GordonMD Long Biased Master Fund LP - 0
GordonMD Long Biased GP LLC - 0
Craig D. Gordon - 0
GordonMD Global Investments GP LLC - 0

**(iv) Shared power to dispose or to direct the disposition of:**

GordonMD Global Investments LP - 3,058,485
GordonMD Long Biased Master Fund LP - 2,735,783
GordonMD Long Biased GP LLC - 2,735,783
Craig D. Gordon - 3,058,485
GordonMD Global Investments GP LLC - 3,058,485

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

All of the securities reported in this Schedule 13G are directly owned by advisory clients of GordonMD Global Investments LP. None of those advisory clients, other than GordonMD Long Biased Master Fund LP, may be deemed to beneficially own more than 5% of the Common Stock, par value $0.00001 per share.

**Item 7. Identification and Classification of the Subsidiary**

Please see Exhibit B attached hereto.

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**GordonMD Global Investments LP**

**Date:** 11/17/2025

**By:** /s/ GordonMD Global Investments GP LLC

**Name & Title:** Craig D. Gordon / Managing Member of the General Partner

**GordonMD Long Biased Master Fund LP**

**Date:** 11/17/2025

**By:** /s/ GordonMD Long Biased GP LLC

**Name & Title:** GordonMD Long Biased GP LLC / Managing Member of the General Partner

**GordonMD Long Biased GP LLC**

**Date:** 11/17/2025

**By:** /s/ Craig D. Gordon

**Name & Title:** Craig D. Gordon / Managing Member

**Craig D. Gordon**

**Date:** 11/17/2025

**By:** /s/ Craig D. Gordon

**Name & Title:** Craig D. Gordon

**GordonMD Global Investments GP LLC**

**Date:** 11/17/2025

**By:** /s/ Craig D. Gordon

**Name & Title:** Craig D. Gordon / Managing Member